We talk about Antarctic extremophiles often. It is worth explaining what happens between discovery and having a kit on a laboratory bench.

1. Discovery

   The organism: a thermophilic bacterium producing a proteinase with the right temperature activation profile was identified from a culture collection of more than 3,000 extremophilic organisms. The selection criterion: inactive at room temperature, highly active at 75°C, completely destroyed at 95°C. Most organisms in the collection do not meet all three.

2. Characterisation

   The enzyme's gene was sequenced and the protein characterised: substrate specificity, pH optimum, salt tolerance, stability in extraction buffers. This work confirmed the enzyme's mechanism and defined the buffer conditions in which it performs reliably.

3. Recombinant Production

   The enzyme is not harvested from the original organism at scale. The gene is expressed in a standard recombinant production host, a well-characterised bacterial expression system, under controlled fermentation conditions. This is how pharmaceutical and industrial enzymes are manufactured routinely.

4. Formulation

   The purified enzyme is formulated with the proprietary buffer system that optimises its activity in the context of a cell lysis reaction: the right ionic strength, the right pH, the right co-factor concentrations. Different kit formulations (𝘱𝘳𝘦𝘱GEM, 𝘧𝘰𝘳𝘦𝘯𝘴𝘪𝘤GEM, 𝘱𝘩𝘺𝘵𝘰GEM, 𝘣𝘰𝘯𝘦GEM) reflect different extraction challenges and downstream application requirements.

5. Quality Control

   Each batch is tested against performance specifications before release.

The Antarctic origin is genuine. The supply chain is robust. These are not the same thing, and both matter.